GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
about
Cannabis and psychosis/schizophrenia: human studiesMarijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalizationCannabinoids reveal separate controls for whisking amplitude and timing in ratsRegulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memoryThe Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for PsychosisΔ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.The role of cannabinoid 1 receptor expressing interneurons in behavior.The effect of chronic cannabinoids on broadband EEG neural oscillations in humans.Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex.Pursuing paradoxical proconvulsant prophylaxis for epileptogenesisCannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder.Cannabinoid-mediated inhibition of recurrent excitatory circuitry in the dentate gyrus in a mouse model of temporal lobe epilepsyIncreased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuseEndocannabinoids in the dentate gyrus.Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and peripheral nervous system.Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans.Cannabis and the brain.Multiple functions of endocannabinoid signaling in the brain.Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.Impact of Cannabis Use on the Development of Psychotic DisordersPreliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla.Hippocampal cannabinoid transmission modulates dopamine neuron activity: impact on rewarding memory formation and social interaction.Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis.Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55,212-2.Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiationThe Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons.Exogenous and endogenous cannabinoids suppress inhibitory neurotransmission in the human neocortexGABA Targets for the Treatment of Cognitive Dysfunction in SchizophreniaDose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamateSusceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes.Cannabinoid modulation of backpropagating action potential-induced calcium transients in layer 2/3 pyramidal neuronsComplementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampusSelf-tuning of inhibition by endocannabinoids shapes spike-time precision in CA1 pyramidal neurons.Endocannabinoid-mediated control of synaptic transmission.Morphology and synaptic input of substance P receptor-immunoreactive interneurons in control and epileptic human hippocampus.Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings.
P2860
Q24628837-59A5645A-1CE3-4F9D-A998-CFB45F09C794Q27009287-C59E43F6-B484-484C-80DE-3A9E29AF8D60Q28293379-D6949105-487A-4782-8617-7E750B3BF402Q28295045-E1358E29-D2B9-40CA-B8DB-A72A4A343204Q30047193-5A2E7547-75B8-429C-B4A7-8433C96610A0Q30377901-CBFF1C9B-8457-4632-B7D4-1B025BD0E3ADQ30417825-29A6D6CE-02C8-4D9D-9D32-F6FA4C6768BCQ30450059-3121FCD2-82B5-476E-9140-FBC5FABD2943Q30494037-AA537436-7322-4D80-B566-B513A0B0F07AQ30495206-76531DCA-D1BB-470F-A3CC-CCE22F2996ADQ30497212-5082D57F-BB16-4C4D-9508-C8CF1AC36A1BQ33586242-DA75CF09-9306-461B-BD2F-550578549F51Q33590705-20AB778C-E10B-40D1-9890-3FAF91E2D327Q33757950-FB01EC96-C2FF-4FC5-BDCB-8DCBAD3A6769Q33897801-411338BD-7AEE-44CA-B7C6-1FCABABA8502Q34015797-E458F673-561A-4FB7-B5F6-29F19E69F7E4Q34199483-342FD20F-8628-48F1-9ECB-B7168FE0E346Q34270199-D26D338D-EBB2-4427-8B8C-016114AA35F4Q34312878-FDBD0263-9433-4530-9A4A-B6133D55266DQ34499364-A415A153-3638-484E-8E5C-F4493CDBCB31Q34668606-372707EC-1CBA-45BE-9FD1-0409E4312DBBQ34730179-400A8F9F-5D07-4A22-815B-3051D525A922Q35421151-9DD860EC-93AD-4446-A64C-2C4BDB358F9CQ35593725-89F754E8-E8FF-4614-9CD4-5528F6E4B000Q35626928-CA072F97-48E4-417D-A6BC-FAA9512BB59CQ35688747-98DA7441-AC6D-4266-BB96-686FC07AC51FQ35818844-A20CC282-1E6E-4C24-83C1-D7AE5DBD0592Q35837682-7DF11924-CB80-4537-953B-1E7CE7F1DA24Q35916950-6B453E28-4E4D-4B85-8D08-CE3CCA3CF399Q35982323-C12BB658-0235-4D2F-A3F7-D7888FDCA3F3Q36358712-A863CBA1-70C6-4D9F-AEE7-71E87130B18EQ36591245-30492802-335C-4C83-A972-BB66DD746AE9Q36726650-B84C9851-12F6-46E3-B113-9F72572692E0Q36904318-E4AE6CF1-DE37-44BE-A761-9D0BCA47AB3FQ36917918-CC2C7B4C-210A-4F85-9FAE-3EFB9E5D5E69Q37235439-D2217102-6790-4A93-86C3-A0412FF06D3DQ37363621-24A4D1B4-E496-40E1-A993-A8538D7E91DFQ37365516-55AD3C10-2565-4932-900E-C7FAAC7375E3Q38056395-C99BFC27-AAE9-4195-8360-07E2FE304696Q38124448-E32C7BCB-1693-40B2-A68E-52323B9BDC78
P2860
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
@en
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
@nl
type
label
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
@en
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
@nl
prefLabel
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
@en
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus.
@nl
P2093
P50
P1433
P1476
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus
@en
P2093
P304
P356
10.1016/S0306-4522(00)00286-4
P407
P577
2000-01-01T00:00:00Z